Biologic and geographic differences between vaccine and clinical varicella-zoster virus isolates

Archives of Virology, Supplement

Volumn , Issue 17, 2001, Pages 41-48

  LaRussa, P S ^a,b   Gershon, A A ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADAPTATION; ARTICLE; CHILD; GENETICS; HERPES ZOSTER; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PHYSIOLOGY; VARICELLA ZOSTER VIRUS; VIROLOGY;

ADAPTATION, PHYSIOLOGICAL; CHICKENPOX VACCINE; CHILD; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS;

EID: 0035228597     PISSN: 09391983     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-7091-6259-0_5     Document Type: Article

References (39)

1. Asano Y, Nakayama H, Yazaki T, Ito S, Isomura S (1977) Protective efficacy of vaccination in children in four episodes of natural varicella and zoster in the ward. Pediatrics 59: 8-12
2. Asano Y, Nakayama H, Yazaki T, Kato R, Hirose S, Tsuzuki K, Ito S, Isomura S, Takahashi M (1977) Protection against varicella in family contacts by immediate inoculation with live varicella vaccine. Pediatrics 59: 3-7
3. Asano Y, Yazaki T, Miyata T, Nakayama H, Hirose S (1975) Application of a live attenuated varicella vaccine to hospitalized children and its protective effect on spread of varicella infection. Biken J 18: 35-40
4. Baba K, Yabuuchi H, Okuni H, Takahashi M (1978) Studies with live varicella vaccine and inactivated skin test antigen: protective effect of the vaccine and clinical application of the skin test. Pediatrics 61: 550
5. Bogger-Goren S, Baba K, Hurley P, Yabuuchi H, Takahashi M, Ogra PL (1982) Antibody response to varicella-zoster virus after natural or vaccine-induced infection. J Infect Dis 146: 260-265
6. Brunell PA, Geiser CF, Novelli V, Lipton S, Narkewicz S (1987) Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia. Pediatrics 79: 922-927
7. Bruusgaard E (1932) The mutual relation between zoster and varicella. Br J Dermatol Syph 44: 1-24
8. Feder HM, Jr LaRussa P, Steinberg S, Gershon AA (1997) Clinical varicella following varicella vaccination: don't be fooled. Pediatrics 99: 897-899
9. Gomi Y, Mori T, Imagawa T, Takahashi M, Yamanishi K (1999) Virus and other clinical isolates of varicella-zoster virus. In: The International Conference on Immunity and Prevention of Herpes Zoster, Osaka, Japan, p 12
10. Hardy IB, Gershon A, Steinberg S, LaRussa P (1991) The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N Engl J Med 325: 1545-1550
11. Hayakawa Y, Torigoe S, Shiraki K, Yamanishi K, Takahashi M (1984) Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients. J Infect Dis 149: 956-963
12. Hayakawa Y, Yamamoto T, Yamanishi K, Takahashi M (1986) Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI. J Gen Virol 67: 1817-1829
13. Just M, Berger R, Luescher D (1985) Live varicella vaccine in healthy individuals. Postgrad Med J 61: 129-132
14. Kamiya H, Kato T, Isaji M, Torigoe S, Oitani K, Ito M, Ihara T, Sakurai M, Takahashi M (1984) Immunization of acute leukemic children with a live varicella vaccine (Oka strain). Biken J 27: 99-102
15. Kinchington PR, Ling P, Pensiero M, Ruyechan WT, Hay J (1990) The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka). J Virol 64: 540-548
16. Kohl S, Rapp J, LaRussa P, Gershon A, Steinberg S (1999) Natural varicella zoster virus reactivation shortly after varicella immunization in a child. Pediatr Infect Dis J 18: 1112-1113
17. Kundratitz K (1925) Experimentelle Ubertragung von Herpes Zoster auf den Mensschen und die Beziehungen von Herpes Zoster zu Varicellen. Monatssbl Kinderheilkd 29: 516-523
18. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S (1992) Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 66: 1016-1020
19. LaRussa P, Steinberg S, Arvin A, Dwyer D, Burgess M, Menegus M, Rekrut K, Yamanishi K, Gershon A (1998) Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J Infect Dis 178 [Suppl 1]: S64-S66
20. LaRussa P, Steinberg S, Gershon A (1994) Diagnosis and typing of varicella-zoster virus (VZV) in clinical specimens by polymerase chain reaction (PCR). In: 34th ICAAC, Orlando, Abstract #1486
21. LaRussa P, Steinberg S, Meurice F, Gershon A (1997) Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts. J Infect Dis 176: 1072-1075
22. LaRussa P, Steinberg S, Sharrar R, Galea S, Gershon A (1997) Identification and differentiation of wild (WT)- and vaccine (OKA)-strain VZV isolates by PCR from recipients of live attenuated varicella vaccine (LAVV). In: 3rd International Conference on the Varicella-Zoster Virus, Palm Beach, Florida, Abstract #P-49
23. Lawrence R, Gershon A, Holzman R, Steinberg S, NIAID Varicella Vaccine Collaborative Study Group (1988) The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med 318: 543-548
24. Martin JH, Dohner DE, Wellinghoff WJ, Gelb LD (1982) Restriction endonuclease analysis of varicella-zoster vaccine virus and wild-type DNAs. J Med Virol 9: 69-76
25. Moffat JF, Zerboni L, Kinchington PR, Grose C, Kaneshima H, Arvin AM (1998) Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72: 965-974
26. Ndumbe PM, Cradock-Watson JE, MacQueen S, Dunn H, Andre F, Davies EG, Dudgeon JA, Levinsky RJ (1985) Immunisation of nurses with a live varicella vaccine. Lancet 1: 1144-1147
27. Plotkin SA, Starr S, Connor K, Morton D (1989) Zoster in normal children after varicella vaccine. J Infect Dis 159: 1000-1001
28. Ross A, Lencher E, Reitman G (1962) Modification of chickenpox in family contacts by administration of gamma globulin. N Engl J Med 267: 369-376
29. Salzman MB, Sharrar RG, Steinberg S, LaRussa P (1997) Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother. J Pediatr 131: 151-154
30. Shapiro E, LaRussa P, Steinberg S, Gershon A (1998) Protective efficacy of varicella vaccine. In: 34th Annual Meeting of The Infectious Diseases Society of America, Denver, Abstract #78
31. Shapiro E, Vazquez M, LaRussa P, Steinberg S, Gershon A (1999) Protective efficacy of varicella vaccine. In: 24th International Herpes Virus Workshop, Boston, Abstract 13.030
32. Sharrar R, LaRussa P, Galea S, Steinberg S, Keatley R, Wells M, Stephenson W, Gershon A (2000) The postmarketing safety profile of varicella vaccine. Vaccine (in press)
33. Takahashi M (1996) The varicella vaccine. Vaccine development. Infect Dis Clin North Am 10: 469-488
34. Takahashi M, Gershon A (1994) Varicella vaccine. In: Mortimer E, Plotkin S (eds) Vaccines. WB Saunders, Philadelphia, pp 387-417
35. Takahashi M, Kamiya H, Baba K, Asano Y, Ozaki T, Horiuchi K (1985) Clinical experience with Oka live varicella vaccine in Japan. Postgrad Med 61: 61-67
36. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S (1974) Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 2: 1288-1290
37. Tsolia M, Gershon AA, Steinberg SP, Gelb L (1990) Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J Pediatr 116: 184-189
38. White C (1992) Varicella vaccine reflux, reply to letter. Pediatrics 89: 354
39. White CJ (1996) Clinical trials of varicella vaccine in healthy children. Infect Dis Clin North Am 10: 595-608